99mTc-MDP* | | | | | |
Administered activity (MBq) | 518 | 407 | 237 | 141 | 73 |
Effective dose in mSv/MBq (mSv) | 0.0057 (3.0) | 0.0070 (2.8) | 0.0110 (2.6) | 0.0140 (2.0) | 0.0270 (2.0) |
Bladder wall in mGy/MBq (mGy) | 0.048 (24.9) | 0.060 (24.4) | 0.088 (20.9) | 0.073 (10.3) | 0.130 (9.5) |
Bone surfaces (mGy) | 0.063 (32.6) | 0.082 (33.4) | 0.130 (30.8) | 0.220 (31.0) | 0.53 (38.7) |
Red marrow (mGy) | 0.0092 (4.8) | 0.010 (4.1) | 0.017 (4.0) | 0.033 (4.7) | 0.067 (4.9) |
18F-labeled NaF† | | | | | |
Administered activity (MBq) | 148 | 116 | 68 | 40 | 21 |
Effective dose in mSv/MBq (mSv) | 0.027 (4.0) | 0.034 (3.9) | 0.052 (3.5) | 0.086 (3.4) | 0.170 (3.6) |
Bladder wall in mGy/MBq (mGy) | 0.22 (32.6) | 0.27 (31.3) | 0.40 (27.2) | 0.61 (24.4) | 1.10 (23.1) |
Bone surfaces in mGy/MBq (mGy) | 0.040 (5.9) | 0.050 (5.8) | 0.079 (5.4) | 0.130 (5.2) | 0.300 (6.3) |
Red marrow in mGy/MBq (mGy) | 0.040 (5.9) | 0.053 (6.1) | 0.088 (6.0) | 0.180 (7.2) | 0.380 (8.0) |